{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:08:33Z","timestamp":1794002913859,"version":"4.8.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,5,8]],"date-time":"2007-05-08T00:00:00Z","timestamp":1178582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2007,7,27]]},"DOI":"10.1007\/s00277-007-0304-8","type":"journal-article","created":{"date-parts":[[2007,5,7]],"date-time":"2007-05-07T03:12:10Z","timestamp":1178507530000},"page":"677-683","source":"Crossref","is-referenced-by-count":54,"title":["Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies"],"prefix":"10.1007","volume":"86","author":[{"given":"Grzegorz","family":"Helbig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Stella-Holowiecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Wojnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slawomira","family":"Krzemien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wojciechowska-Sadus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miros\u0142aw","family":"Markiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Wylezol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Kopera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Holowiecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,8]]},"reference":[{"issue":"4","key":"304_CR1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1046\/j.1365-2141.1999.1331d.x","volume":"104","author":"P Bavaro","year":"1999","unstructured":"Bavaro P, Di Girolamo G, Olioso P, Papalinetti G, Iacone A, Accorsi P, Di Bartolomeo (1999) Donor lymphocyte infusion as therapy for pure red cell aplasia following bone marrow transplantation. Br J Haematol 104(4):930\u2013931","journal-title":"Br J Haematol"},{"key":"304_CR2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00007890-198204000-00017","volume":"33","author":"WI Bensinger","year":"1982","unstructured":"Bensinger WI, Buckner CD, Thomas ED, Clift RA (1982) ABO-incompatible marrow transplants. Transplantation 33:427\u2013429","journal-title":"Transplantation"},{"key":"304_CR3","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood.V98.6.1687","volume":"98","author":"CD Bolan","year":"2001","unstructured":"Bolan CD, Leitman SF, Griffith LM, Wesley RA, Procter JL, Stroncek DF, Barrett J, Childs RW (2001) Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 98:1687\u20131694","journal-title":"Blood"},{"key":"304_CR4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/sj.bmt.1705378","volume":"37","author":"UR Deotare","year":"2006","unstructured":"Deotare UR, Vishwabandya A, Mathews V, George B, Srivastava A, Chandy M (2006) Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation. Bone Marrow Transplant 37:1149\u20131150","journal-title":"Bone Marrow Transplant"},{"key":"304_CR5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood.V75.1.290.290","volume":"75","author":"J Gmur","year":"1990","unstructured":"Gmur J, Burger J, Schaffner A, Neftel K, Oelz O, Frey D, Metaxas M (1990) Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 75:290\u2013295","journal-title":"Blood"},{"key":"304_CR6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2141.2005.05364.x","volume":"128","author":"LM Griffith","year":"2005","unstructured":"Griffith LM, McCoy JP Jr, Bolan CD, Stroncek DF, Pickett AC, Linton GF, Lundqvist A, Srinivasan R, Leitman SF, Childs RW (2005) Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation. Br J Haematol 128:668\u2013675","journal-title":"Br J Haematol"},{"issue":"Suppl","key":"304_CR7","first-page":"ECR33","volume":"90","author":"G Helbig","year":"2005","unstructured":"Helbig G, Stella-Holowiecka B, Krawczyk-Kulis M, Wojnar J, Markiewicz M, Wojciechowska-Sadus M, Kopera M, Kruzel T, Najda J, Nowak K, Holowiecki J (2005) Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in 2 patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia. Haematologica 90(Suppl):ECR33","journal-title":"Haematologica"},{"key":"304_CR8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2141.1983.tb01996.x","volume":"53","author":"JM Hows","year":"1983","unstructured":"Hows JM, Chipping PM, Palmer S, Gordon-Smith EC (1983) Regeneration of peripheral blood cells following ABO incompatible allogeneic bone marrow transplantation for severe aplastic anaemia. Br J Haematol 53:145\u2013151","journal-title":"Br J Haematol"},{"key":"304_CR9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood.V77.4.906.906","volume":"77","author":"A Hyell","year":"1991","unstructured":"Hyell A, Aul C, Runde V, Arning M, Schneider W, Wernet P (1991) Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin. Blood 77:906","journal-title":"Blood"},{"key":"304_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.bmt.1702121","volume":"25","author":"JH Lee","year":"2000","unstructured":"Lee JH, Lee KH, Kim S, Lee JS, Kim SH, Kwon SW, Kim WK (2000) Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation. Bone Marrow Transplant 25:179\u2013184","journal-title":"Bone Marrow Transplant"},{"key":"304_CR11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1046\/j.1365-2141.2003.04128.x","volume":"120","author":"JH Lee","year":"2003","unstructured":"Lee JH, Lee JH, Choi SJ, Kim S, Soel M, Kwon SW, Park CJ, Chi HS, Lee JS, Kim WK, Lee KH (2003) Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation. Br J Haematol 120:702\u2013710","journal-title":"Br J Haematol"},{"key":"304_CR12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1703668","volume":"30","author":"AA Maschan","year":"2002","unstructured":"Maschan AA, Skorobogatova EV, Balsashov DN, Pashanov ED, Trakhtman PE, Schipitizina IP, Skvortsova YV, Rumiantzev AG (2002) Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral allogeneic stem cell transplantation for acquired aplastic anemia. Bone Marrow Transplant 30:405\u2013407","journal-title":"Bone Marrow Transplant"},{"key":"304_CR13","first-page":"853","volume":"15","author":"J Mehta","year":"1995","unstructured":"Mehta J, Powles R, Horton C, Milan S, Singhal S, Treleaven J (1995) Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings. Bone Marrow Transplant 15:853\u2013858","journal-title":"Bone Marrow Transplant"},{"key":"304_CR14","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V96.3.1150","volume":"96","author":"M Mielcarek","year":"2000","unstructured":"Mielcarek M, Leisenring W, Torok-Storb B, Storb R (2000) Graft-versus-host disease and donor-directed hemagglutinin titrem after ABO-mismatched related and unrelated marrow allografts: evidence for graft -versus-plasma cell effect. Blood 96:1150\u20131156","journal-title":"Blood"},{"key":"304_CR15","first-page":"99","volume":"4","author":"R Or","year":"1991","unstructured":"Or R, Naparstek E, Mani N, Slavin S (1991) Treatment of pure red cell aplasia following ABO-incompatible bone marrow transplantation: two case reports with successful response to plasmapheresis. Transpl Int 4:99\u2013102","journal-title":"Transpl Int"},{"key":"304_CR16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1537-2995.1993.33593255604.x","volume":"33","author":"O Paltiel","year":"1993","unstructured":"Paltiel O, Cournoyer D, Rybka W (1993) Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin. Transfusion 33:418\u2013421","journal-title":"Transfusion"},{"key":"304_CR17","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1182\/blood.V99.12.4642","volume":"99","author":"KS Pegs","year":"2002","unstructured":"Pegs KS, Morris EC, Kottaridis PD, Geary J, Goldstone AH, Linch DC, Mackinnon S (2002) Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen. Blood 99:4642\u20134644","journal-title":"Blood"},{"key":"304_CR18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/sj.bmt.1704264","volume":"32","author":"W Rabitsch","year":"2003","unstructured":"Rabitsch W, Knobl P, Prinz E, Keil F, Greinix H, Kahls P, Worel N, Jansen M, Horl WH, Derfler K (2003) Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb\u00ae immunoadsorption. Bone Marrow Transplant 32:1015\u20131019","journal-title":"Bone Marrow Transplant"},{"key":"304_CR19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bmt.1701012","volume":"12","author":"A Santamaria","year":"1997","unstructured":"Santamaria A, Sureda A, Martino R, Domingo-Albos A, Muniz-Diaz E, Brunet S (1997) Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin. Bone Marrow Transplant 12:1105\u20131107","journal-title":"Bone Marrow Transplant"},{"key":"304_CR20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1537-2995.2005.04236.x","volume":"45","author":"J Schetelig","year":"2005","unstructured":"Schetelig J, Breitschaft A, Kroger N, Zabelina T, Ebell W, Bornhauser M, Haack A, Ehninger G, Salama A, Siegert W (2005) After major ABO-mismatched allogeneic hematopoietic progenitor stem cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B. Transfusion 45:779","journal-title":"Transfusion"},{"key":"304_CR21","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bbmt.2005.07.015","volume":"11","author":"JD Seebach","year":"2005","unstructured":"Seebach JD, Stussi G, Passweg JR, Loberiza FR Jr, Gajewski JL, Keating A, Goerner M, Rowlings PA, Tiberghien P, Elfenbein GJ, Gale RP, van Rood JJ, Reddy V, Gluckman E, Bolwell BJ, Klumpp TR, Horowitz MM, Ringden O, Barret AJ (2005) GVHD Working Committee of Center for International Blood and Marrow Transplant Research. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant 11:1006\u20131013","journal-title":"Biol Blood Marrow Transplant"},{"key":"304_CR22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.0041-1132.2005.00445.x","volume":"45","author":"F Sora","year":"2005","unstructured":"Sora F, De Matteis S, Piccirillo N, Chiusolo P, Laurenti L, Putzulu R, Leone G, Sica S (2005) Rituximab for pure red cell aplasia after ABO-mismatched allogeneic peripheral blood progenitor cell transplantation. Transfusion 45:643\u2013644","journal-title":"Transfusion"},{"key":"304_CR23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0609.2004.00320.x","volume":"73","author":"F Verholen","year":"2004","unstructured":"Verholen F, Stadler M, Helg C, Chalandon Y (2004) Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion. Eur J Haematol 73:441\u2013446","journal-title":"Eur J Haematol"},{"key":"304_CR24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1537-2995.2000.40050543.x","volume":"40","author":"N Worel","year":"2000","unstructured":"Worel N, Greinix HT, Schneider B, Kurz M, Rabitsch W, Knobl P, Reiter E, Derfler K, Fischer G, Hintenberger W, Hocker P, Kahls P (2000) Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion 40:543\u2013550","journal-title":"Transfusion"},{"key":"304_CR25","doi-asserted-by":"crossref","first-page":"195197","DOI":"10.1159\/000205063","volume":"84","author":"L Volin","year":"1990","unstructured":"Volin L, Ruutu T (1990) Pure red-cell aplasia of long duration after major ABO-incompatible bone marrow transplantation. Acta Haematol 84:195\u2013197","journal-title":"Acta Haematol"},{"key":"304_CR26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002770000275","volume":"80","author":"MH Yang","year":"2001","unstructured":"Yang MH, Hsu HC (2001) Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anaemia with response to steroids: a case report and literature review. Ann Hematol 80:299\u2013301","journal-title":"Ann Hematol"},{"key":"304_CR27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/10245330410001714202","volume":"10","author":"K Zhu","year":"2005","unstructured":"Zhu K, Chen J, Chen S (2005) Treatment of Epstein\u2013Barr virus-associated lymphoproliferative disorder (EBV\u2013PTLD) and pure red cell aplasia (PRCA) with rituximab following unrelated cord blood transplantation: a case report and literature review. Hematology 10:365\u2013370","journal-title":"Hematology"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0304-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-007-0304-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0304-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T15:28:05Z","timestamp":1587482885000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-007-0304-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,8]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,7,27]]}},"alternative-id":["304"],"URL":"https:\/\/doi.org\/10.1007\/s00277-007-0304-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1086754.539668","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,8]]}}}